Published in Curr Opin Immunol on October 01, 1999
Design of a minimal protein oligomerization domain by a structural approach. Protein Sci (2000) 1.09
Predominant antitumor effects by fully human anti-TRAIL-receptor 2 (DR5) monoclonal antibodies in human glioma cells in vitro and in vivo. Neuro Oncol (2010) 0.85
Floridoside extracted from the red alga Mastocarpus stellatus is a potent activator of the classical complement pathway. Mar Drugs (2008) 0.83
Depletion of synovial macrophages in rheumatoid arthritis by an anti-FcgammaRI-calicheamicin immunoconjugate. Ann Rheum Dis (2004) 0.80
Targeting CD19 in B-cell lymphoma: emerging role of SAR3419. Cancer Manag Res (2013) 0.79
Natural and non-natural amino-acid side-chain substitutions: affinity and diffraction studies of meditope-Fab complexes. Acta Crystallogr F Struct Biol Commun (2016) 0.75
Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet (1994) 1.13
Molecular cloning and characterization of alternatively spliced transcripts of the mouse neurofibromatosis 2 gene. Cancer Res (1994) 0.87
Enhanced antitumor activity of paclitaxel in combination with the anticarcinoma immunoconjugate BR96-doxorubicin. Clin Cancer Res (1999) 0.83
Changes in keratin expression during 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis. Cancer Res (1990) 0.83
Early expression of type I K13 keratin in the progression of mouse skin papillomas. Carcinogenesis (1990) 0.83
Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice. Cancer Res (1992) 0.78
Activating mutation of the Ha-ras gene in chemically induced tumors of the hamster cheek pouch. Mol Carcinog (1992) 0.77
Unexpected Prad-1 amplification in multiple simultaneous localisations of squamous cell carcinoma of the head and neck. Eur J Cancer (1993) 0.76
A novel polymorphism near the mouse Int-2 locus. Mamm Genome (1992) 0.75
Tumor suppressor genes in squamous cell carcinoma. Prog Clin Biol Res (1992) 0.75